“The journey to healing could not begin until I had an accurate diagnosis.” Rhonda’s story is only one of the millions of examples that highlight the importance of having access to timely and accurate diagnosis of cardiovascular diseases (#CVD). Changing the burden related to this non-communicable disease requires increased investments in establishing national CVD strategies focused on prevention and early detection. This should include expanding access to cardiac biomarkers and increasing workforce training to enable the effective use of existing and new technologies that improve outcomes for patients and health systems. It's fantastic to see the Council of the European Union encouraging European countries to prioritise prevention, early detection, treatment and rehabilitation in the recently approved draft for an EU CVD Action Plan! I really hope to see similar initiatives in other regions as well. This way we can ensure that stories like Rhonda's are prevented from happening! #HeartHealth #CVD #ActOnNCDs
Stefan Seliger’s Post
More Relevant Posts
-
You already know Symphony Health’s IDV® powers commercial insights to drive brand growth. Did you know Symphony's RWD and analytics experts also provide insights for medical teams? The observational study featured below examines the underlying risk of tendon injuries among ASCVD patients. How can we help you?
Symphony Health, an ICON plc company, is pleased to announce the publication of a significant study leveraging our real-world data to explore the prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease (ASCVD). This retrospective, observational study provides critical insights that can help healthcare providers assess the underlying risk factors and guide more effective treatment plans for this vulnerable patient population. Click here to explore the findings and their implications for clinical practice: https://ow.ly/PyyZ50SJOZx. #HealthcareResearch #ASCVD #RealWorldData #SymphonyHealth
-
-
Symphony Health’s IDV® provides insights to help healthcare providers determine the underlying risk of tendon injuries and guide treatment of the patient population in this retrospective, observational study. How can we help you?
Symphony Health, an ICON plc company, is pleased to announce the publication of a significant study leveraging our real-world data to explore the prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease (ASCVD). This retrospective, observational study provides critical insights that can help healthcare providers assess the underlying risk factors and guide more effective treatment plans for this vulnerable patient population. Click here to explore the findings and their implications for clinical practice: https://ow.ly/PyyZ50SJOZx. #HealthcareResearch #ASCVD #RealWorldData #SymphonyHealth
-
-
Symphony Health’s IDV® provides insights to help healthcare providers determine the underlying risk of tendon injuries and guide treatment of the patient population in this retrospective, observational study. How can we help you?
Symphony Health, an ICON plc company, is pleased to announce the publication of a significant study leveraging our real-world data to explore the prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease (ASCVD). This retrospective, observational study provides critical insights that can help healthcare providers assess the underlying risk factors and guide more effective treatment plans for this vulnerable patient population. Click here to explore the findings and their implications for clinical practice: https://ow.ly/PyyZ50SJOZx. #HealthcareResearch #ASCVD #RealWorldData #SymphonyHealth
-
-
🌟 Advancing Medical Knowledge Through Groundbreaking Research 🌟 🩺 Ambulance-Based BP Management in Stroke A study finds that intensive blood pressure reduction during ambulance transport in hyperacute stroke doesn’t improve outcomes over standard care. This insight refines prehospital stroke management strategies. 🧬 Autoantibodies and Inflammatory Bowel Disease Rare cases of neutralizing autoantibodies against interleukin-10 in children with IBD highlight new therapeutic possibilities and deepen understanding of disease mechanisms. 🌡️ Postacute Sequelae of SARS-CoV-2 A comprehensive analysis of 441,583 veterans across the pre-Delta, Delta, and Omicron eras offers critical data to improve care and guide future research on long COVID. Source- https://lnkd.in/gyiFMWtR #OpioidCrisis #ReproductiveHealth #MaternalCare #PublicHealthInnovation
-
-
Symphony Health’s IDV® provides insights to help healthcare providers determine the underlying risk of tendon injuries and guide treatment of the patient population in this retrospective, observational study. How can we help you? https://lnkd.in/eAWQyy2K
Symphony Health, an ICON plc company, is pleased to announce the publication of a significant study leveraging our real-world data to explore the prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease (ASCVD). This retrospective, observational study provides critical insights that can help healthcare providers assess the underlying risk factors and guide more effective treatment plans for this vulnerable patient population. Click here to explore the findings and their implications for clinical practice: https://ow.ly/PyyZ50SJOZx. #HealthcareResearch #ASCVD #RealWorldData #SymphonyHealth
-
-
Proven Strategic Marketer | Helping Companies Translate Their Business Goals to Reality
Symphony Health’s IDV® is leveraged to provide insights to help healthcare providers determine the underlying risk of tendon injuries and guide treatment of the patient population in this retrospective, observational study. How can we help you? https://ow.ly/PyyZ50SJOZx
Symphony Health, an ICON plc company, is pleased to announce the publication of a significant study leveraging our real-world data to explore the prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease (ASCVD). This retrospective, observational study provides critical insights that can help healthcare providers assess the underlying risk factors and guide more effective treatment plans for this vulnerable patient population. Click here to explore the findings and their implications for clinical practice: https://ow.ly/PyyZ50SJOZx. #HealthcareResearch #ASCVD #RealWorldData #SymphonyHealth
-
-
Symphony Health’s IDV® provides insights to help healthcare providers determine the underlying risk of tendon injuries and guide treatment of the patient population in this retrospective, observational study. How can we help you?
Symphony Health, an ICON plc company, is pleased to announce the publication of a significant study leveraging our real-world data to explore the prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease (ASCVD). This retrospective, observational study provides critical insights that can help healthcare providers assess the underlying risk factors and guide more effective treatment plans for this vulnerable patient population. Click here to explore the findings and their implications for clinical practice: https://ow.ly/PyyZ50SJOZx. #HealthcareResearch #ASCVD #RealWorldData #SymphonyHealth
-
-
Join MedSci in this NUHCS - National University Heart Centre, Singapore outreach community event where we will be launching the Summit dopplers for Peripheral Vascular Screening from CooperSurgical in Singapore! #PAD #HeartHealth #Diabetics #PVD Discover the latest technology in: - Early detection of Peripheral Artery Disease (PAD) - Enhanced diagnosis for heart health - Improved screening for diabetics - Accurate Peripheral Vascular Disease (PVD) diagnosis
-
-
A veteran | Research Scholar | Advanced Certified Scrum Product Owner® (A-CSPO®) | Information Technology Consulting and Services | Custom Software Development | Application Modernization | Enterpreneur
𝗧𝗵𝗲 𝗜𝗻𝘁𝗲𝗿𝘀𝗲𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗕𝗶𝗴 𝗗𝗮𝘁𝗮 𝗮𝗻𝗱 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲: 𝗠𝗮𝗻𝗮𝗴𝗶𝗻𝗴 𝗖𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗥𝗶𝘀𝗸 Big data is transforming how healthcare providers manage cardiovascular risk. By analyzing vast datasets from EHRs and using graph technology, healthcare providers can identify high-risk patients, predict disease progression, and offer tailored treatments. This data-driven approach is essential for reducing the burden of cardiovascular diseases in populations. #BigDataInHealthcare #CardiovascularRisk #EHR #GraphTechnology #DataDrivenCare
-
✴️ New results have been published estimating the testing requirement to double the diagnostic rates of ≥ F2 MASH over a 5-year period in France, Germany, UK and USA! ➡️ By doubling this rate in all four countries, the number of patients diagnosed will increase from 2.6m to 6.1m between 2022 and 2027. To achieve this, several approaches need to be set up: >> Early intervention is both possible and desirable, to improve outcomes and reduce costs >> More screening calls are needed to strengthen healthcare infrastructure >> Doubling the diagnoses and multiplying the collaborative efforts >> A person-centered approach Echosens supports and advances the liver health management and diagnosis with its gold-standard non-invasive solutions in order to improve the management of silent and under-diagnosed chronic liver diseases. Check the poster now 👉 https://lnkd.in/gPAXqiWe Jeffrey V. Lazarus #FibroScan #LiverHealthMatters #EASL2024
-
